Search

everythinglearnresearchcommunity

for

Search:↓

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Phospholipase A2 enzymes play key roles in skin health and disease.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

Increased blood vessel growth in lichen planopilaris may signal active disease needing aggressive treatment.

Sarcoidosis can cause various skin issues, making diagnosis difficult.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

A new tool allows easier long-term imaging of live skin cells, helping study diseases like skin cancer.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

A combined Dermatology and Rheumatology Clinic showed that skin issues often weren't linked to rheumatic diseases, highlighting the benefits of a team approach.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Alopecia is common in lupus patients, causing significant anxiety and is linked to the disease itself.

The document suggests a possible link between frontal fibrosing alopecia and rosacea.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.